Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C

Authors:	Ajit Sood Praveen Sobti Vandana Midha Dinesh Singla Amarjeet Kaur Sandeep Kaushal Neena Sood Rasham Mittal Sandeep Puri

Affiliation:	(1) Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, 141 001, India;(2) Department of Medicine, Dayanand Medical College and Hospital, Ludhiana, India;(3) Department of Community Medicine, Dayanand Medical College & Hospital, Ludhiana, India;(4) Dayanand Medical College & Hospital, Ludhiana, India;(5) Department of Pathology, Dayanand Medical College and Hospital, Ludhiana, India;(6) Department of Transfusion Medicine, Dayanand Medical College & Hospital, Ludhiana, India

Abstract:	Background Treatment of HCV infection in patients with thalassemia major (TM) is limited by the lack of large clinical trials and concerns about ribavirin-induced hemolysis.

Keywords:
本文献已被 SpringerLink 等数据库收录！